Alyeska Investment Group
AVIR icon

Alyeska Investment Group’s Atea Pharmaceuticals AVIR Stock Holding History

Alyeska Investment Group’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-75,000
Closed -$3.13M – 714
2020
Q4 		$3.13M Buy
+75,000
New +$3.13M 0.04% 325